Co-Locating COVID-19 Vaccination, Infectious Disease Testing With Syringe Services Program Boosted Engagement Among People Who Injected Drugs, Study Finds

MedPage Today (6/3, Firth) reports, “Co-locating COVID-19 vaccination and infectious disease testing with a syringe services program boosted engagement among people who injected drugs, according to an analysis of the Baltimore-based initiative.” In the study, “among 347 participants across 10 co-located clinics participating in the Baltimore City Health Department Syringe Services Program from April 2021 to June 2022, 63% received at least one dose of the COVID vaccine and 58% received one infectious disease test, reported” researchers in Health Affairs.